Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology

BMJ. 1996 Aug 31;313(7056):539-44. doi: 10.1136/bmj.313.7056.539.

Authors

M P Vanderpump¹, J A Ahlquist, J A Franklyn, R N Clayton

Affiliation

¹ Department of Diabetes and Endocrinology, City General Hospital, Stoke on Trent.

No abstract available

Publication types

Consensus Development Conference
Research Support, Non-U.S. Gov't
Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Carbimazole / therapeutic use
Female
Fetal Diseases / therapy
Humans
Hyperthyroidism / diagnosis
Hyperthyroidism / therapy*
Hypothyroidism / diagnosis
Hypothyroidism / therapy*
Iodine Radioisotopes / therapeutic use
Pregnancy
Pregnancy Complications / therapy
Propylthiouracil / therapeutic use
Referral and Consultation
Thyroid Function Tests
Thyroidectomy
Thyroxine / therapeutic use
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Iodine Radioisotopes
Propylthiouracil
Carbimazole
Thyroxine